Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-25-003224

Chief Financial Officer acquired 165,156 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Francisco David Chief Financial Officer 2025-02-19 Grant or award +165,156 559,095 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Francisco David Chief Financial Officer 2025-02-19 Grant or award · Stock Option (Right to Buy) +170,841 170,841 D: show line 2 in the form
Loading xslF345X05/form4.xml…